Skip to content
CTD // Fund

Medytox Venture

Corporate venture capital focusing on investments in healthcare, biotech, and medical devices

← Fund directory

Medytox Venture

South Korea

Medytox Venture is an institutional investor (Healthcare Startups) founded in 2017 and headquartered in Seoul, South Korea. Corporate venture capital focusing on investments in healthcare, biotech, and medical devices. It focusing its investments in healthcare and bio industries. As an institutional investor, the firm manages capital on behalf of institutional limited partners, deploying capital across selected investment opportunities with strong growth potential.

Stage
Seed, Series A, Series B, Series C, Seed, Series A, Series B, Series C
Check size
$1M-$10M
HQ
Seoul, South Korea
Founded
2017
Website
http://medytoxventure.com
Institutional Investorbiotechbiopharmamedtechhealthcaremedical devices

What they look for

Innovative ideas addressing unmet needs with competitive advantages and patentable technology; primarily Korean tech startups via TIPS program; R&D and AI focus in bio/medical

Related startups

AIGEN Sciences

AIGEN Sciences provides AI-based drug discovery and design tools for researchers, featuring its proprietary AIGEN Discovery platform.

HealthTech · Seoul, South Korea

SigIQ.ai

AI-powered platform offering education and learning solutions. It is an education technology platform leveraging artificial intelligence to accelerate human…

EdTech · Berkeley, United States

Claned

Claned provides an Ai-powered learning platform for educational institutions and corporates. It offers a personalized and adaptive learning platform for…

EdTech · Helsinki, Finland

📊 Revenue multiples by stage & sector — free comps-based startup valuation calculator.

⚠️ Common pitch mistakes we see →

Preparing to pitch Medytox Venture?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →